Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, announces cUHDRS subcomponent data from the twelve-month ...

Background High-efficacy disease-modifying therapies (HETs) have substantially improved multiple sclerosis (MS) management, yet ongoing cognitive decline remains a concern. This study aims to assess ...

Regular moderate to high intensity aerobic exercise may help preserve physical function in early-stage Parkinson disease, according to a cross-sectional study comparing active and low-active ...

Adults who eat more ultra-processed foods show measurably slower thinking on standardized cognitive tests, and the effect ...

There is an inseparable relationship between cognitive decline and cardiovascular disease. In particular, there is a close connection with cerebrovascular disease, and it is a well-known fact that ...

CHARLOTTE, N.C. — Plasma neurofilament light chain (NfL) levels tracked closely with cognitive function in patients with relapsing multiple sclerosis (RMS), a new analysis showed, adding more evidence ...

bDanish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark cDepartment of Neurology and Center of Clinical Neuroscience, First Faculty ...

On June 30th, Skyhawk Therapeutics shared a press release with new twelve-month data from the ongoing Phase 1/2 trial of ...

Brain injury that occurs after birth is termed as “Acquired Brain injury (ABI)”. ABI is an umbrella term that refers to traumatic brain injury (TBI) and non-traumatic brain injury. TBI is an external ...

aDivision of Neurology, Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada bCenter for Neuroinflammation and Experimental Therapeutics and Division of multiple ...